Physician profile
Timothy Ross Stuart
NPI 1952558058
$1,683.62
in general payments reported to CMS, 2019-2025
16 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $519 · 2022: $448 · 2023: $249 · 2024: $90.92 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $397.57 | 2021-2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $247.93 | 2021-2023 | Farxiga |
| Novo Nordisk INC | $188.49 | 2021-2025 | Ozempic |
| Abbvie INC. | $172.03 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $162.35 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $124.77 | 2021 | |
| Lilly USA, LLC | $75.67 | 2021-2023 | Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $73.18 | 2022 | |
| Cranial Technologies, INC | $52.02 | 2023-2025 | Doc Band |
| Pfizer INC. | $51.86 | 2021-2025 | |
| Amarin Pharma, INC. | $37.74 | 2021 | |
| Abbott Laboratories | $29.00 | 2025 | Triclip |
| Amgen INC. | $26.59 | 2022 | |
| Antares Pharma, INC. | $17.21 | 2025 | Xyosted |
| Merck Sharp & Dohme LLC | $14.70 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.